Prevalence of undiagnosed Type 2 diabetes and impaired fasting glucose in older British men and women

Diabetic Medicine

Volumn 22, Issue 6, 2005, Pages 789-793

  Thomas, Mary C ^a   Walker, M K ^a   Emberson, J R ^a   Thomson, A G ^a   Lawlor, D A ^b   Ebrahim, S ^b   Whincup, P H ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Impaired fasting glucose; Prevalence; Type 2 diabetes; WHO criteria

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL EXAMINATION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; WORLD HEALTH ORGANIZATION;

EID: 20444385892     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01516.x     Document Type: Article

References (24)

1. Department of Health. National Service Framework for Diabetes: Standards. 2001. London, UK: Department of Health.
2. Venkat Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes - a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Prac 2000; 50: S77-S84.
3. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
4. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
5. Williams R, Wild S. Diabetes prevalence data for the United Kingdom-what do we have and what do we need? Diabet Med 2003; 20: 505-506.
6. Simmons D, Williams D, Powell M. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Quart J Med 1991; 81: 1021-1030.
7. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-94. Diabetes Care 1998; 21: 518-524.
8. DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 1998; 317: 371-375.
9. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Geneva: World Health Organization, 1999.
10. Shaper AG, Pocock SJ, Walker M, Cohen MN, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J 1981; 283: 179-186.
11. Thomas MC, Walker M, Lennon LT, Thomson AG, Lampe FC, Shaper AG. Non-attendance at re-examination 20 years after screening in the British Regional Heart Study. J Public Health Med 2002; 24: 285-291.
12. Lawlor D, Bedford C, Taylor M, Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart Health Study. JECH 2003; 57: 134-140.
13. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol 1969; 22: 246.
14. Emberson J, Whincup P, Walker M, Thomas M, Alberti K. Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem 2002; 39: 493-501.
15. Troisi RJ, Cowie CC, Harris MI. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. J Am Med Assoc 2000; 284: 3157-3159.
16. Erens B, Primatesta P, eds. Health Survey for England 1998. London: The Stationery Office, 1999.
17. Riste L, Khan F, Cruickshank K. High prevalence of Type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? Diabetes Care 2001; 24: 1377-1383.
18. International Diabetes Federation. Diabetes Atlas. Brussels: International Diabetes Federation, 2003. http://www.ldf.org/e-atlas
19. The DECODA Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26: 1770-1780.
20. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
21. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to Type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003; 52: 1475-1484.
22. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR et al. United Kingdom Prospective Diabetes Study, 30: Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297-303.
23. Colagiuri S, Cull CA, Holman RR. Are lower fasting plasma glucose levels at diagnosis of Type 2 diabetes associated with improved outcomes? UK Prospective Diabetes Study 61. Diabetes Care 2002; 25: 1410-1417.
24. Wareham NJ, Griffin SJ. Should we screen for Type 2 diabetes? Evaluation against National Screening Committee criteria. Br Med J 2001; 322: 986-988.